Risk factors for lung cancer worldwide

European Respiratory Journal

Volumn 48, Issue 3, 2016, Pages 889-902

  Malhotra, Jyoti ^a,b   Malvezzi, Matteo ^c,d   Negri, Eva ^d   La Vecchia, Carlo ^c   Boffetta, Paolo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BETA CAROTENE; CADMIUM; METAL; POLYCYCLIC AROMATIC HYDROCARBON; SILICON DIOXIDE;

AIR POLLUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIETARY INTAKE; EXHAUST GAS; FAMILY HISTORY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IONIZING RADIATION; LUNG CANCER; LUNG TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; DIET; DRINKING BEHAVIOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; INFLAMMATION; LUNG TUMOR; MALE; TOBACCO;

ALCOHOL DRINKING; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFLAMMATION; LUNG NEOPLASMS; MALE; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TOBACCO;

EID: 84986224243     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00359-2016     Document Type: Article

References (121)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
2. Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2016 with focus on leukemias. Ann Oncol 2016; 27: 725-731.
3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, IARC, 2013.
4. Foreman D, Bray F, Brewster DH, et al., eds. Cancer Incidence in Five Continents. Volume X. Lyon, International Agency for Research on Cancer, 2014.
5. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.
6. Malvezzi M, Bosetti C, Rosso T, et al. Lung cancer mortality in European men: trends and predictions. Lung Cancer 2013; 80: 138-145.
7. World Health Organization. WHO Statistical Information System (WHOSIS). www.who.int/healthinfo/mortality-data/en/Date last updated: November 25, 2015. Date last accessed: December 15, 2015.
8. Hashim D, Boffetta P, La Vecchia C, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol 2016; 27: 926-933.
9. Graham H. Smoking prevalence among women in the European community 1950-1990. Soc Sci Med 1996; 43: 243-254.
10. Franceschi S, Naett C. Trends in smoking in Europe. Eur J Cancer Prev 1995; 4: 271-284.
11. Thun M, Peto R, Boreham J, et al. Stages of the cigarette epidemic on entering its second century. Tob Control 2012; 21: 96-101.
12. Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2012. Ann Oncol 2012; 23: 1044-1052.
13. Bailey-Wilson JE, Sellers TA, Elston RC, et al. Evidence for a major gene effect in early-onset lung cancer. J La State Med Soc 1993; 145: 157-162.
14. Lorenzo Bermejo J, Hemminki K. Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1738-1740.
15. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004; 75: 460-474.
16. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238.
17. Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 2011; 43: 792-796.
18. Miki D, Kubo M, Takahashi A, et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet 2010; 42: 893-896.
19. Hosgood HD III, Wang WC, Hong YC, et al. Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hum Genet 2012; 131: 1197-1203.
20. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008; 40: 1404-1406.
21. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009; 85: 679-691.
22. Truong T, Hung RJ, Amos CI, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010; 102: 959-971.
23. Hsiung CA, Lan Q, Hong YC, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010; 6: e1001051.
24. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008; 40: 1407-1409.
25. Brenner DR, Brennan P, Boffetta P, et al. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet 2013; 132: 579-589.
26. Timofeeva MN, Hung RJ, Rafnar T, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet 2012; 21: 4980-4995.
27. Shi J, Chatterjee N, Rotunno M, et al. Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov 2012; 2: 131-139.
28. Dong J, Jin G, Wu C, et al. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in Han Chinese. PLoS Genet 2013; 9: e1003190.
29. Li Y, Sheu CC, Ye Y, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010; 11: 321-330.
30. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622.
31. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642.
32. Lan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012; 44: 1330-1335.
33. Ahn MJ, Won HH, Lee J, et al. The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet 2012; 131: 365-372.
34. Liu JZ, Tozzi F, Waterworth DM, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 436-440.
35. Saccone NL, Culverhouse RC, Schwantes-An TH, et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 2010; 6: e1001053.
36. Fernandez-Garcia I, Ortiz-de-Solorzano C, Montuenga LM. Telomeres and telomerase in lung cancer. J Thorac Oncol 2008; 3: 1085-1088.
37. Zhao J, Gupta S, Seielstad M, et al. Pathway-based analysis using reduced gene subsets in genome-wide association studies. BMC Bioinform 2011; 12: 17.
38. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 2012; 8: e1002375.
39. Wang Y, McKay JD, Rafnar T, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 2014; 46: 736-741.
40. Wynder EL. Tobacco as a cause of lung cancer: some reflections. Am J Epidemiol 1997; 146: 687-694.
41. Peto R, Boreham J, Lopez AD, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke. In: Tobacco smoke and involuntary smoking. Vol 83. Lyon, World Health Organization/IARC, 2004; pp. 51-1187.
43. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
44. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
45. Devesa SS, Grauman DJ, Blot WJ, et al. Cancer surveillance series: changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994. J Natl Cancer Inst 1999; 91: 1040-1050.
46. Yuan J-M, Koh W-P, Murphy SE, et al. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res 2009; 69: 2990-2995.
47. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Involuntary Smoking. In: Tobacco smoke and involuntary smoking. Vol 83. Lyon, World Health Organization/IARC, 2004; pp. 1191-1413.
48. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-988.
49. Boffetta P. Involuntary smoking and lung cancer. Scand J Work Environ Health 2002; 28: Suppl. 2, 30-40.
50. Stayner L, Bena J, Sasco AJ, et al. Lung cancer risk and workplace exposure to environmental tobacco smoke. Am J Public Health 2007; 97: 545.
51. Boffetta P, Trédaniel J, Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ Health Perspect 2000; 108: 73.
52. Henley SJ, Thun MJ, Connell C, et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005; 16: 347-358.
53. Lam TK, Gallicchio L, Lindsley K, et al. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomark Prev 2009; 18: 184-195.
54. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, AICR, 2007.
55. Vieira AR, Abar L, Vingeliene S, et al. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol 2016; 27: 81-96.
56. Sinha R, Kulldorff M, Curtin J, et al. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control 1998; 9: 621-630.
57. Sinha R, Kulldorff M, Swanson CA, et al. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res 2000; 60: 3753-3756.
58. Smith-Warner SA, Ritz J, Hunter DJ, et al. Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomark Prev 2002; 11: 987-992.
59. Albanes D. Carotene and lung cancer: a case study. Am J Clin Nutr 1999; 69: 1345s-1350s.
60. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with ? carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
61. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 1994; 4: 1-10.
62. Greenwald P. Carotene and lung cancer: a lesson for future chemoprevention investigations? J Natl Cancer Inst 2003; 95: E1-E1.
63. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12: 31.
64. Guertin KA, Freedman ND, Loftfield E, et al. Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. Int J Epidemiol 2015 [in press DOI: 10.1093/ije/dyv104].
65. Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res 2006; 50: 144-151.
66. Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and lung cancer risk in never smokers: a meta-analysis. Ann Oncol 2011; 22: 2631-2639.
67. Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer a review of the epidemiologic evidence. Cancer Epidemiol Biomark Prev 2001; 10: 813-821.
68. Korte JE, Brennan P, Henley SJ, et al. Dose-specific meta-analysis and sensitivity analysis of the relation between alcohol consumption and lung cancer risk. Am J Epidemiol 2002; 155: 496-506.
69. Freudenheim JL, Ritz J, Smith-Warner SA, et al. Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 2005; 82: 657-667.
70. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149: 13-20.
71. Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995; 141: 1023-1032.
72. Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer 1987; 40: 604-609.
73. Powell HA, Iyen-Omofoman B, Baldwin DR, et al. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol 2013; 8: 6-11.
74. Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003; 14: 327-334.
75. Rosenberger A, Bickeboller H, McCormack V, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis 2012; 33: 587-597.
76. Aoki K. Excess incidence of lung cancer among pulmonary tuberculosis patients. Jpn J Clin Oncol 1993; 23: 205-220.
77. Zheng W, Blot W, Liao M, et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 1987; 56: 501-505.
78. Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomark Prev 2005; 14: 773-778.
79. Anantharaman D, Gheit T, Waterboer T, et al. No causal association identified for human papillomavirus infections in lung cancer. Cancer Res 2014; 74: 3525-3534.
80. Colombara DV, Manhart LE, Carter JJ, et al. Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study. Cancer Causes Control 2015; 26: 1835-1844.
81. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lung. In: Ionizing Radiation, Part 1: X-and Gamma (y)-Radiation, and Neutrons. Vol 75. Lyon, World Health Organization/IARC, 2000; pp. 253-254.
82. Boice JD. Ionizing radiation. In: Schottenfeld D, Fraumenu JJ, eds. Cancer Epidemiology and Prevention. New York, Oxford University Press, 1996; pp. 319-354.
83. International Agency for Research on Cancer, World Health Organization. Weight Control and Physical Activity. Volume 6. Lyon, IARC Press, 2002.
84. Lubin JH. Radon and lung cancer risk: a joint analysis of 11 underground miners studies. Washington, National Institutes of Health, 1994.
85. Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330: 223.
86. Krewski D, Lubin JH, Zielinski JM, et al. A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health Part A 2006; 69: 533-597.
87. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011; 103: 1827-1839.
88. Rushton L, Hutchings SJ, Fortunato L, et al. Occupational cancer burden in Great Britain. Br J Cancer 2012; 107: Suppl 1, S3-S7.
89. Boffetta P, Autier P, Boniol M, et al. An estimate of cancers attributable to occupational exposures in France. J Occup Environ Med 2010; 52: 399-406.
90. IARC Monographs. Chemical agents and related occupations. Volume 100 F. A review of human carcinogens. Lyon, World Health Organization/IARC, 2012.
91. Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 2008; 38: Suppl. 1, 1-47.
92. Gilham C, Rake C, Burdett G, et al. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med 2016; 7: 290-299.
93. Hayes RB. The carcinogenicity of metals in humans. Cancer Causes Control 1997; 8: 371-385.
94. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Cadmium. In: Volume 58 Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. Lyon, World Health Organization/IARC, 1993; pp. 119-238.
95. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Arsenic in drinking-water. In: Volume 84 Some Drinking-water Disinfectants and Contaminants, including Arsenic. Lyon, World Health Organization/IARC, 2004; pp. 39-267.
96. Steenland K, Stayner L. Silica, asbestos, man-made mineral fibers, and cancer. Cancer Causes Control 1997; 8: 491-503.
97. Steenland K, Mannetje A, Boffetta P, et al. Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control 2001; 12: 773-784.
98. Bosetti C, Boffetta P, La Vecchia C. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol 2007; 18: 431-446.
99. Rota M, Bosetti C, Boccia S, et al. Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: an updated systematic review and a meta-analysis to 2014. Arch Toxicol 2014; 88: 1479-1490.
100. Benbrahim-Tallaa L, Baan RA, Grosse Y, et al. Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol 2012; 13: 663-664.
101. Silverman DT, Samanic CM, Lubin JH, et al. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst 2012; 104: 855-868.
102. Olsson AC, Gustavsson P, Kromhout H, et al. Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med 2011; 183: 941-948.
103. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 95 Household use of solid fuels and high-temperature frying. Lyon, World Health Organization/IARC, 2006.
104. Lissowska J, Bardin-Mikolajczak A, Fletcher T, et al. Lung cancer and indoor pollution from heating and cooking with solid fuels: the IARC international multicentre case-control study in Eastern/Central Europe and the United Kingdom. Am J Epidemiol 2005; 162: 326-333.
105. Krewski D, Jerrett M, Burnett RT, et al. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst 2009; 140: 5-114.
106. Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013; 14: 813-822.
107. McDonnell WF, Nishino-Ishikawa N, Petersen FF, et al. Relationships of mortality with the fine and coarse fractions of long-term ambient PM10 concentrations in nonsmokers. J Expo Anal Environ Epidemiol 2000; 10: 427-436.
108. Laden F, Schwartz J, Speizer FE, et al. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006; 173: 667-672.
109. Loomis D, Huang W, Chen G. The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China. Chin J Cancer 2014; 33: 189-196.
110. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest J 2005; 128: 370-381.
111. Schabath MB, Wu X, Vassilopoulou-Sellin R, et al. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004; 10: 113-123.
112. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
113. Olsson H, Bladstrom A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003; 102: 565-570.
114. Kreuzer M, Gerken M, Heinrich J, et al. Hormonal factors and risk of lung cancer among women? Int J Epidemiol 2003; 32: 263-271.
115. Blackman JA, Coogan PF, Rosenberg L, et al. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 2002; 11: 561-567.
116. Taioli E, Wynder EL. Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994; 86: 869-870.
117. Adami HO, Persson I, Hoover R, et al. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833-839.
118. Wu AH, Mimi CY, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988; 48: 7279-7284.
119. Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012; 18: 382-384.
120. Henley SJ, Flanders WD, Manatunga A, et al. Leanness and lung cancer risk: fact or artifact? Epidemiology 2002; 13: 268-276.
121. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.